Targeting ATM-deficient CLL through interference with DNA repair pathways
Open Access
- 10 June 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 6, 207
Abstract
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in the Western world and accounts for approximately 30% of adult leukemias and 25% of non-Hodgkin lymphomas. The median age at diagnosis is 72 years. During recent years numerous genetic aberrations have been identified that are associated with an aggressive course of the disease and resistance against genotoxic chemotherapies. The DNA damage-responsive proapoptotic ATM-CHK2-p53 signaling pathway is frequently mutationally inactivated in CLL either through large deletions on chromosome 11q (ATM) or 17p (TP53), or through protein-damaging mutations. Here, we focus on the role of ATM signaling for the immediate DNA damage response, DNA repair and leukemogenesis. We further discuss novel therapeutic concepts for the targeted treatment of ATM-defective CLLs. We specifically highlight the potential use of PARP1 and DNA-PKcs inhibitors for the treatment of ATM-mutant CLL clones. Lastly, we briefly discuss the current state of genetically engineered mouse models of the disease and emphasize the use of these preclinical tools as a common platform for the development and validation of novel therapeutic agents.Keywords
This publication has 102 references indexed in Scilit:
- Playing the End Game: DNA Double-Strand Break Repair Pathway ChoiceMolecular Cell, 2012
- ATM and Artemis promote homologous recombination of radiation‐induced DNA double‐strand breaks in G2The EMBO Journal, 2009
- Phospho‐dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damageEMBO Reports, 2008
- Mutation Status of the Residual ATM Allele Is an Important Determinant of the Cellular Response to Chemotherapy and Survival in Patients With Chronic Lymphocytic Leukemia Containing an 11q DeletionJournal of Clinical Oncology, 2007
- DNA damage checkpoints: from initiation to recovery or adaptationCurrent Opinion in Cell Biology, 2007
- ATM stabilizes DNA double-strand-break complexes during V(D)J recombinationNature, 2006
- Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complexOncogene, 2006
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- Cell cycle checkpoint signaling through the ATM and ATR kinasesGenes & Development, 2001
- Radiation-induced Assembly of Rad51 and Rad52 Recombination Complex Requires ATM and c-AblJournal of Biological Chemistry, 1999